Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001595585-21-000077
Filing Date
2021-06-11
Accepted
2021-06-11 17:09:52
Documents
1
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162344577105495.html 4  
1 FORM 4 wf-form4_162344577105495.xml 4 6248
  Complete submission text file 0001595585-21-000077.txt   7648
Mailing Address C/O AXOVANT SCIENCES, INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018
Business Address
FALBERG KATHRYN E (Reporting) CIK: 0001206977 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38558 | Film No.: 211012208

Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Issuer) CIK: 0001595585 (see all company filings)

EIN.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations